Intractable disseminated maculopapular eruption in a patient with granulocyte macrophage colony‐stimulating factor‐producing anaplastic thyroid carcinoma

Abstract

1 Berger M, Legeay AL, Souci S, Streichenberger N, Thomas L, Dalle S. Pembrolizumab-induced dermatomyositis in a patient with metastatic melanoma. Eur J Cancer 2018; 104: 227–230. 2 Kudo F, Watanabe Y, Iwai Y et al. Advanced lung adenocarcinoma with nivolumab-associated dermatomyositis. Intern Med 2018; 57: 2217–2221. 3 Yamaguchi Y, Abe R, Haga N, Shimizu H. A case of drug-associated dermatomyositis following ipilimumab therapy. Eur J Dermatol 2016; 26: 320–321. 4 Sheik Ali S, Goddard AL, Luke JJ et al. Drug-associated dermatomyositis following ipilimumab therapy: a novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade. JAMA Dermatol 2015; 151: 195–199. 5 Fiorentino DF, Chung LS, Christopher-Stine L et al. Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1c. Arthritis Rheum 2013; 65: 2954–2962.